News >

Adjuvant Options Arrive for Melanoma

Tony Hagen @oncobiz
Published: Thursday, Nov 08, 2018

Hussein A. Tawbi, MD, PhD

Hussein A. Tawbi, MD, PhD

The treatment armamentarium for adjuvant melanoma has expanded rapidly, which has left the treatment challenge of selecting between immunotherapy and targeted therapy without any head-to-head comparative data. When picking a type of therapy, Hussein Tawbi, MD, PhD, recommended communicating the relative merits and risks of both options to patients and making a shared decision.
... to read the full story
To Read the Full Story

View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Publication Bottom Border
Border Publication